Current Trends in the Biomedical Sciences Topics and Lecturers

Please note that Quicktime Streams may take some time to launch, as they are large and must buffer a portion before starting.

August 29th – Dr. Harold Shlevin, President and CEO, Tikvah Therapeutics: Initial course meeting of all students and instructors to introduce course. Overview of Disease. Class slides (PDF)   Lecture (Quicktime stream)

Please note that the audio quality of the first lecture is less than optimal due to technical issues which are now being corrected. Use of headphones is advised when viewing the first lecture online.

September 5th - Dr. David Mason, UCB Pharma, Inc.: Defining “disease” or medical need; Identifying unmet medical needs and markets for products (risk assessment); Criteria for identifying a marketable product to pursue. Class slides (PDF) Lecture (Quicktime stream)

September 12th - Dr. Robert McNally, CEO, Cell Dynamics, LLC: Identifying the ideal characteristics of targeted product; Identifying how the product differs from existing products; Identifying what has already been done or what others are currently doing in this area; How to make money on your product/idea (limitations of market size, limitations of your product output); Identifying the goals for what the product does. Class slides (PDF) Lecture Part 1 (Quicktime stream) Lecture Part 2 (Quicktime stream)

September 19th - Dr. Yashwant Deo, CEO, AviGenics, Inc.: Gathering information about relevant science (what science has already been done and who is doing the relevant science); Identifying any relevant patents that already exist; Introduction to preclinical and clinical phases of product development. No course slides available for this date. Lecture (Quicktime stream)

September 26th (class meeting cancelled) – Dr. Earl Sands, VP Research and Development, Acting Chief Medical Officer, Solvay Pharmaceuticals, Inc.: Identifying the science that needs to get done and how to do it (what questions to ask and how to answer them).

October 3rd – Georgia Life Sciences Summit 2007, Georgia World Congress Center: Students registered for this course will be registered free of charge for this Summit. For more information about the summit log on to: http://www.informedhorizons.com/summit2007 

October 10th - Dr. Robert McNally, CEO, Cell Dynamics, LLC: Preclinical studies: design and implementation (bioinformatics, biostatistics, pharmacokinetics and toxicology, data collection, managing data); Human dimension: bioinformatics, biostatistics, selecting patients, data collection, managing information, distribution, pharmacokinetics, Phase I trials, link to toxicology studies. Class slides (PDF)  Lecture Part 1 (Quicktime stream) Lecture Part 2 (Quicktime stream)

October 17th – Dr. Troy L. ZumBrunnen, PharmD, BCPP, Clinical Pharmacology, Solvay Pharmaceuticals, Inc. Clinical Drug Development: What are the questions and how do we answer them? Class slides (PDF) Lecture Part 1 (Quicktime stream) Lecture Part 2 (Quicktime stream)

*October 24th – Dr. Russ Medford, President and CEO, AtheroGenics, Inc.: Review and approval process (from the point of the FDA and product developer). Class slides (PDF) Lecture (Quicktime stream)

* Location for this class meeting Spelman College

October 31st – Dr. Chris Offen, CEO, Wynden Pharmaceuticals, LLC: Marketing practices for product launch (how to communicate information, sales force management). Class slides (PDF) Lecture (Quicktime stream)

November 7th - Lynn Hood, President, Hood Marketing Solutions: Public relations, reimbursement (success attracts attention and take-over offers). Decisiontree Handout (PDF) 2008 ALPHA Handout (PDF) Class slides (PDF) Lecture (Quicktime stream)

November 14th – Dr. Laurence Downey, President and CEO, Solvay Pharmaceuticals, Inc.: Current & future trends in industry; Internships for students in participating companies. (online slides will not be available for this date)  Lecture Part 1(Quicktime stream) Lecture Part 2(Quicktime stream)

November 28th – Course instructors at individual institutions: Final course meeting of students and instructors at individual institutions

BACK